March 20 (Reuters) - Roche has stopped developing its experimental drug for two rare muscle diseases after it failed to show meaningful benefits, the Swiss drugmaker said in community letters. Here are some details: * In the letters, dated March 19, the company said it would no longer pursue the drug, emugrobart, for spinal muscular atrophy, or SMA, and facioscapulohumeral...

By Yadarisa Shabong, Neil J Kanatt and Savyata Mishra March 20 (Reuters) - Spice maker McCormick ( MKC ) has built a reputation as a savvy acquirer in the past decade, turning brands like Frank's RedHot and French's mustard into growth drivers that now account for a sizeable chunk of its $6.8 billion in annual sales, analysts say. McCormick's (...

01:03 PM EDT, 03/20/2026 (MT Newswires) -- FedEx's ( FDX ) strong fiscal third quarter highlights momentum for a company that's growing market share in an uncertain global trade environment, BofA Securities said in a note sent to clients on Friday. Late Thursday, FedEx ( FDX ) reported a surprise increase in fiscal third-quarter earnings as gains in domestic package...

01:02 PM EDT, 03/20/2026 (MT Newswires) -- Banco Macro ( BMA ) and Fintech Digital agreed to purchase all of the outstanding stock and voting rights of Banco Saenz from a trio of individual investors for $2 million plus an amount in Argentine pesos equal to shareholders' equity to be determined before closing. The sellers are Liliana Monica Fravega, Facundo...